|
GB8827305D0
(en)
|
1988-11-23 |
1988-12-29 |
British Bio Technology |
Compounds
|
|
IL97459A0
(en)
*
|
1990-03-09 |
1992-06-21 |
Hybritech Inc |
Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent
|
|
US5091542A
(en)
*
|
1990-03-09 |
1992-02-25 |
Hybritech Incorporated |
Tris-maleimido compounds as intermediates in trifunctional antibody synthesis
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
ES2227512T3
(es)
|
1991-12-02 |
2005-04-01 |
Medical Research Council |
Produccion de anticuerpos contra auto-antigenos a partir de repertorios de segmentos de anticuerpos fijados en un fago.
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
US20080152586A1
(en)
|
1992-09-25 |
2008-06-26 |
Avipep Pty Limited |
High avidity polyvalent and polyspecific reagents
|
|
US5455258A
(en)
|
1993-01-06 |
1995-10-03 |
Ciba-Geigy Corporation |
Arylsulfonamido-substituted hydroxamic acids
|
|
JPH08175990A
(ja)
|
1994-12-19 |
1996-07-09 |
Mitsubishi Chem Corp |
Ｐｉ３キナーゼ阻害剤とその製造法
|
|
JPH08176070A
(ja)
|
1994-12-19 |
1996-07-09 |
Mitsubishi Chem Corp |
ジデプシド誘導体及びｐｉ３キナーゼ阻害剤
|
|
US6355780B1
(en)
|
1995-02-22 |
2002-03-12 |
Yeda Research And Development Co. Ltd. |
Antibodies to the death domain motifs of regulatory proteins
|
|
US5863949A
(en)
|
1995-03-08 |
1999-01-26 |
Pfizer Inc |
Arylsulfonylamino hydroxamic acid derivatives
|
|
DK0821671T3
(da)
|
1995-04-20 |
2001-04-23 |
Pfizer |
Arylsulfonylhydroxamsyrederivater som MMP- og TNF-inhibitorer
|
|
GB9521987D0
(en)
|
1995-10-26 |
1996-01-03 |
Ludwig Inst Cancer Res |
Phosphoinositide 3-kinase modulators
|
|
GB9624482D0
(en)
|
1995-12-18 |
1997-01-15 |
Zeneca Phaema S A |
Chemical compounds
|
|
DE69624081T2
(de)
|
1995-12-20 |
2003-06-12 |
Agouron Pharmaceuticals, Inc. |
Matrix-metalloprotease Inhibitoren
|
|
PL194689B1
(pl)
|
1996-02-13 |
2007-06-29 |
Astrazeneca Uk Ltd |
Pochodne chinazoliny, ich kompozycje farmaceutyczne oraz ich zastosowania
|
|
EP0885198B1
(en)
|
1996-03-05 |
2001-12-19 |
AstraZeneca AB |
4-anilinoquinazoline derivatives
|
|
EP0818442A3
(en)
|
1996-07-12 |
1998-12-30 |
Pfizer Inc. |
Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor
|
|
YU1899A
(sh)
|
1996-07-18 |
2000-03-21 |
Pfizer Inc. |
Inhibitori matričnih metaloproteaza na bazi fosfinata
|
|
EA199900139A1
(ru)
|
1996-08-23 |
1999-08-26 |
Пфайзер, Инк. |
Производные арилсульфониламиногидроксамовой кислоты
|
|
GB9718972D0
(en)
|
1996-09-25 |
1997-11-12 |
Zeneca Ltd |
Chemical compounds
|
|
AU5131998A
(en)
|
1997-01-06 |
1998-08-03 |
Pfizer Inc. |
Cyclic sulfone derivatives
|
|
US6303636B1
(en)
|
1997-02-03 |
2001-10-16 |
Pfizer Inc |
Arylsulfonylamino hydroxamic acid derivatives
|
|
AU5493598A
(en)
|
1997-02-07 |
1998-08-26 |
Pfizer Inc. |
N-hydroxy-beta-sulfonyl-propionamide derivatives and their use as inhibitors of matrix metalloproteinases
|
|
CN1247531A
(zh)
|
1997-02-11 |
2000-03-15 |
辉瑞大药厂 |
芳基磺酰基异羟肟酸衍生物
|
|
ATE359515T1
(de)
|
1997-02-12 |
2007-05-15 |
Electrophoretics Ltd |
Proteinmarker für lungenkrebs und deren verwendung
|
|
JP2002501721A
(ja)
|
1997-08-01 |
2002-01-22 |
モルフォシス・アクチェンゲゼルシャフト |
多量体（ポリ）ペプチドコンプレックスのメンバーをコードする核酸配列を同定するための新規方法およびファージ
|
|
PL338633A1
(en)
|
1997-08-08 |
2000-11-06 |
Pfizer Prod Inc |
Derivatives of aryloxyarylsuphonylamino hydroxamic acid
|
|
GB9725782D0
(en)
|
1997-12-05 |
1998-02-04 |
Pfizer Ltd |
Therapeutic agents
|
|
GB9801690D0
(en)
|
1998-01-27 |
1998-03-25 |
Pfizer Ltd |
Therapeutic agents
|
|
JP4462654B2
(ja)
|
1998-03-26 |
2010-05-12 |
ソニー株式会社 |
映像素材選択装置及び映像素材選択方法
|
|
PA8469501A1
(es)
|
1998-04-10 |
2000-09-29 |
Pfizer Prod Inc |
Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico
|
|
PA8469401A1
(es)
|
1998-04-10 |
2000-05-24 |
Pfizer Prod Inc |
Derivados biciclicos del acido hidroxamico
|
|
ATE260255T1
(de)
|
1998-11-05 |
2004-03-15 |
Pfizer Prod Inc |
5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
|
|
US7115396B2
(en)
|
1998-12-10 |
2006-10-03 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
|
US6897044B1
(en)
|
1999-01-28 |
2005-05-24 |
Biogen Idec, Inc. |
Production of tetravalent antibodies
|
|
TR200500745T2
(tr)
|
1999-02-10 |
2005-05-23 |
Astrazeneca Ab |
Damar gelişimi inhibitörleri olarak kuinazolin türevleri.
|
|
JP3522727B2
(ja)
|
1999-11-05 |
2004-04-26 |
アストラゼネカ アクチボラグ |
Ｖｅｇｆ阻害剤としてのキナゾリン誘導体
|
|
PT1255752E
(pt)
|
2000-02-15 |
2007-10-17 |
Pharmacia & Upjohn Co Llc |
Inibidores de proteína quinases: 2-indolinonas substituídas com pirrolo
|
|
JP2001247477A
(ja)
|
2000-03-03 |
2001-09-11 |
Teikoku Hormone Mfg Co Ltd |
抗腫瘍剤
|
|
US6403588B1
(en)
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
|
US6608053B2
(en)
|
2000-04-27 |
2003-08-19 |
Yamanouchi Pharmaceutical Co., Ltd. |
Fused heteroaryl derivatives
|
|
US7417130B2
(en)
|
2000-09-08 |
2008-08-26 |
University Of Zurich |
Collection of repeat proteins comprising repeat modules
|
|
ATE290882T1
(de)
|
2001-01-16 |
2005-04-15 |
Glaxo Group Ltd |
Pharmazeutische mischung gegen krebs, die ein 4- chinazolinamin in kombination mit paclitaxel, carboplatin or vinorelbine enthält
|
|
US6441163B1
(en)
|
2001-05-31 |
2002-08-27 |
Immunogen, Inc. |
Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
|
|
CA2454976C
(en)
|
2001-07-26 |
2011-05-10 |
Santen Pharmaceutical Co., Ltd. |
Therapeutic agent for glaucoma comprising compound having pi3 kinase inhibitory action as active ingredient
|
|
EP1412389A1
(en)
|
2001-07-31 |
2004-04-28 |
The University Of Southampton |
Binding agents with differential activity
|
|
US6703414B2
(en)
|
2001-09-14 |
2004-03-09 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Device and method for treating restenosis
|
|
WO2003034997A2
(en)
|
2001-10-24 |
2003-05-01 |
Iconix Pharmaceuticals, Inc. |
Modulators of phosphoinositide 3-kinase
|
|
WO2003035618A2
(en)
|
2001-10-24 |
2003-05-01 |
Iconix Pharmaceuticals, Inc. |
Modulators of phosphoinositide 3-kinase
|
|
AU2002356871A1
(en)
|
2001-10-30 |
2003-05-12 |
Pharmacia Corporation |
Heteroaromatic carboxamide derivatives for the treatment of inflammation
|
|
US20050276812A1
(en)
|
2004-06-01 |
2005-12-15 |
Genentech, Inc. |
Antibody-drug conjugates and methods
|
|
CA2489779A1
(en)
|
2002-07-10 |
2004-01-22 |
Applied Research Systems Ars Holding N.V. |
Use of compounds for increasing spermatozoa motility
|
|
US20040092561A1
(en)
|
2002-11-07 |
2004-05-13 |
Thomas Ruckle |
Azolidinone-vinyl fused -benzene derivatives
|
|
MXPA05000453A
(es)
|
2002-07-10 |
2005-03-23 |
Applied Research Systems |
Derivados de benceno fusionados a azolidinona-vinilo.
|
|
PT2357006E
(pt)
|
2002-07-31 |
2016-01-22 |
Seattle Genetics Inc |
Conjugados de fármacos e sua utilização para tratamento do cancro, de uma doença autoimune ou de uma doença infeciosa
|
|
AU2003255845A1
(en)
|
2002-08-22 |
2004-03-11 |
Piramed Limited |
Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
|
|
CA2504818C
(en)
|
2002-11-07 |
2013-04-23 |
Immunogen, Inc. |
Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same
|
|
US8088387B2
(en)
|
2003-10-10 |
2012-01-03 |
Immunogen Inc. |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
|
|
NZ550772A
(en)
|
2004-05-21 |
2009-10-30 |
Uab Research Foundation |
Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof
|
|
TR201808537T4
(tr)
*
|
2004-09-23 |
2018-07-23 |
Genentech Inc |
Sistein değiştirilmiş antikorlar ve konjugatlar.
|
|
GB0423653D0
(en)
|
2004-10-25 |
2004-11-24 |
Piramed Ltd |
Pharmaceutical compounds
|
|
US8431558B2
(en)
|
2004-11-01 |
2013-04-30 |
The Regents Of The University Of California |
Compositions and methods for modification of biomolecules
|
|
JP2008521828A
(ja)
|
2004-11-29 |
2008-06-26 |
シアトル ジェネティックス， インコーポレイテッド |
操作された抗体およびイムノコンジュゲート
|
|
CA2597407C
(en)
|
2005-02-11 |
2013-09-10 |
Immunogen, Inc. |
Process for preparing stable drug conjugates
|
|
BRPI0613593A2
(pt)
|
2005-07-08 |
2011-01-18 |
Univ Zuerich |
método de teste "phage display" filamentoso, vetor de fago ou de fagomìdeo e biblioteca de vetores de fago ou fagomìdeo
|
|
NZ595430A
(en)
|
2005-08-24 |
2013-05-31 |
Immunogen Inc |
Process for preparing maytansinoid antibody conjugates
|
|
GB0520657D0
(en)
|
2005-10-11 |
2005-11-16 |
Ludwig Inst Cancer Res |
Pharmaceutical compounds
|
|
US8623356B2
(en)
|
2005-11-29 |
2014-01-07 |
The University Of Sydney |
Demibodies: dimerization-activated therapeutic agents
|
|
WO2007098611A1
(en)
|
2006-03-03 |
2007-09-07 |
Queen's University At Kingston |
Compositions for treatment of cancer
|
|
RS54163B1
(sr)
*
|
2006-05-30 |
2015-12-31 |
Genentech Inc. |
Anti-cd22 antitela, njihovi imunokonjugati i njihova upotreba
|
|
US8301398B2
(en)
|
2006-06-22 |
2012-10-30 |
Walter And Eliza Hall Institute Of Medical Research |
Structure of the insulin receptor ectodomain
|
|
AU2008251608B2
(en)
|
2007-05-08 |
2014-03-27 |
Genentech, Inc. |
Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates
|
|
CN106432496B
(zh)
*
|
2007-07-16 |
2020-02-07 |
健泰科生物技术公司 |
抗cd79b抗体和免疫偶联物及使用方法
|
|
CA2700391A1
(en)
|
2007-09-24 |
2009-04-02 |
University Of Zuerich |
Designed armadillo repeat proteins
|
|
GB0724360D0
(en)
|
2007-12-14 |
2008-01-23 |
Glaxosmithkline Biolog Sa |
Method for preparing protein conjugates
|
|
EP2247620B1
(en)
|
2008-01-31 |
2016-05-18 |
Genentech, Inc. |
Anti-cd79b antibodies and immunoconjugates and methods of use
|
|
KR101764927B1
(ko)
|
2008-04-30 |
2017-08-03 |
이뮤노젠 아이엔씨 |
가교제 및 그 용도
|
|
EP2350112A4
(en)
|
2008-10-03 |
2013-01-16 |
Advanced Proteome Therapeutics Inc |
Site specific N-termin protein modifications and conjugate formation
|
|
PT2356269T
(pt)
|
2008-10-31 |
2016-09-13 |
Janssen Biotech Inc |
Composições, métodos e usos de scaffolds baseados em domínios de fibronectina tipo iii
|
|
JP5873335B2
(ja)
|
2009-02-12 |
2016-03-01 |
ヤンセン バイオテツク，インコーポレーテツド |
フィブロネクチンｉｉｉ型ドメインに基づくスカフォールド組成物、方法及び使用
|
|
WO2010141566A1
(en)
|
2009-06-03 |
2010-12-09 |
Immunogen, Inc. |
Conjugation methods
|
|
JP2013514788A
(ja)
|
2009-12-23 |
2013-05-02 |
アビペップ ピーティーワイ リミテッド |
イムノコンジュゲート及びその作製方法２
|
|
TWI796132B
(zh)
|
2010-02-24 |
2023-03-11 |
美商免疫遺傳股份有限公司 |
葉酸受體１抗體類和免疫共軛物類及彼等之用途
|
|
DK2563753T6
(en)
|
2010-04-27 |
2016-04-04 |
Synaffix Bv |
Fused cyclooctynforbindelser and their use in metal-free click-reactions
|
|
ES2730693T3
(es)
|
2010-04-30 |
2019-11-12 |
Janssen Biotech Inc |
Composiciones del dominio de fibronectina estabilizados, métodos y usos
|
|
AU2011265054B2
(en)
|
2010-06-08 |
2016-09-15 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
|
CN103269712B
(zh)
*
|
2010-11-03 |
2016-09-21 |
伊缪诺金公司 |
包含新型安丝菌素衍生物的细胞毒性剂
|
|
RS58367B1
(sr)
|
2011-03-29 |
2019-03-29 |
Immunogen Inc |
Priprema konjugata antitela i majtanzinoida jednostepenim postupkom
|
|
WO2012145112A2
(en)
*
|
2011-04-18 |
2012-10-26 |
Immunogen, Inc. |
Novel maytansinoid derivatives with sulfoxide linker
|